FDA Inspection
K.D. Pharma Bexbach GmbHK.D. Pharma Bexbach GmbH – FDA Inspection, Jun 16, 2017
Record Details
This FDA Inspection record concerns K.D. Pharma Bexbach GmbH, with an inspection on June 16, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- Yumi J. Hiramine (Issuing Officer)
View Company Profile
ID · e69186d5-3db4-41ff-9ef6-4923fac0f043
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1020492
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of K.D. Pharma Bexbach GmbH
3| Date | Classification | Office | Project area |
|---|---|---|---|
| April 19, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 14, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 20, 2012 | NAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
Other documents for K.D. Pharma Bexbach GmbH
- FDA Inspection 1289824 - 2023-04-19
- FDA Inspection 1160099 - 2020-05-14
- FDA Inspection 779536 - 2012-03-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.